Bajaj Consumer Care Q2 Results: Profit jumps 66% YoY to Rs 70 crore, revenue rises 25%

Bajaj Consumer Care reported a 66% year-on-year (YoY) jump in profit after tax (PAT) to Rs 70.2 crore in the second quarter of FY27, compared with Rs 42.3 crore in the corresponding quarter of the previous fiscal.

The company's total operating income rose 25.4% YoY to Rs 332.8 crore in Q2FY27, against Rs 265.3 crore reported in Q2FY26. Earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 71% to Rs 83.3 crore from Rs 48.7 crore in the year-ago quarter.

For the first half of FY27, Bajaj Consumer Care's PAT jumped 74.8% YoY to Rs 140.9 crore from Rs 80.6 crore in H1FY26. Revenue rose 25.2% to Rs 674.3 crore from Rs 538.6 crore, while EBITDA increased 85% to Rs 167.6 crore from Rs 90.6 crore in the corresponding period last fiscal.


ALSO READ: Sebi proposes market cap-based SME IPO norms, seeks public comments on regulatory overhaul

Domestic business sustains strong momentum

Bajaj Consumer Care said its domestic business continued to deliver strong momentum, with revenue growth of more than 30% in both Q2FY27 and H1FY27. The growth was supported by robust double-digit unit volume growth.

Price Point Packs continued to outperform the overall portfolio and remained a key growth driver. The company also introduced a new integrated campaign with revised positioning towards the end of the quarter.

General Trade (GT) sustained its momentum, delivering mid-twenties YoY growth in Q2FY27, while first-half growth remained in the high twenties. Rural markets edged ahead of urban markets during the quarter, with both segments recording robust and closely matched growth.

Organised Trade (OT) delivered high-twenties growth in Q2FY27, building on the momentum of the previous quarter and growing ahead of General Trade.

E-commerce and Modern Trade continued to report broad-based growth across customers and sub-channels, with quick commerce remaining the fastest-growing channel within this segment.

Growth portfolio continues to scale up

The company's Growth Portfolio sustained its strong momentum, continuing to scale up while improving profitability.

The coconut portfolio remained the key growth engine, supported by healthy consumer and trade traction. Bajaj Consumer Care said volume growth was significantly ahead of revenue growth amid deflation in coconut prices.

The company is also continuing to refine its portfolio through the revamp of select brands and the introduction of new products. These products are being piloted in select markets and channels.

International business maintains growth momentum

Bajaj Consumer Care's international business continued to report strong growth in Q2FY27, expanding significantly ahead of the company's overall growth rate.

The Rest of the World (RoW) business sustained its turnaround, while Nepal and the GCC and Africa markets delivered very strong growth.

Bangladesh maintained growth in the teens despite a challenging operating environment, the company said.

Bajaj Consumer Care share price

Shares of Bajaj Consumer Care ended Wednesday's trading session at Rs 520.05 apiece on the NSE, up 2.325% from the previous close of Rs 508.25.

The stock has nearly doubled investors' money in 2026, rallying 96.42%, according to NSE data.

At the closing price, Bajaj Consumer Care's market capitalisation stood at Rs 6,792.81 crore on the NSE.

Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here